Creative Medical Technology Holdings, Inc. (CELZ)
Develops stem cell treatments for erectile dysfunction, diabetes, back pain, and infertility.
$0.74-0.07%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-74.3%
The outlook
CELZ trades at $0.74, well below both its 50- and 200-day moving averages and sitting near its 52-week low. Analyst coverage is sparse but shows an average price target roughly 26× the current price, suggesting extreme valuation disagreement. The StockGlow score of 19/100 leans bearish overall.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +2616% vs current price
Market cap
$4.8M
52-wk high
$6.25
52-wk low
$0.71
50-day avg
$1.65
200-day avg
$2.20
Trailing P/E
—